Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Share Buyback Programme

8 Jan 2026 07:00

RNS Number : 0707O
Softcat PLC
08 January 2026
 

8 January 2026

 

SOFTCAT plc

('Softcat', the 'Group')

 

Share buyback programme

Softcat plc (LSE: SCT.L), a leading UK provider of IT infrastructure products and services, today announces the commencement of a share buyback programme (the 'Programme') to repurchase ordinary shares of £0.0005 each (the 'Shares') for aggregate consideration of up to £45 million. The Programme commences today, 8 January 2026 and is expected to complete in the first half of the calendar year.

The Programme is consistent with the Group's disciplined capital allocation policy and reflects the Board's continued confidence in Softcat's long-term prospects, supported by the Group's strong cash generation and robust financial position.

Details of the Programme

Softcat has entered into a non-discretionary agreement with J.P. Morgan Securities plc ('J.P. Morgan') to conduct the buyback on its behalf and, acting as riskless principal, carry out on-market purchases of Shares (including, for the avoidance of doubt, in the case of any purchases made during closed periods). J.P. Morgan will simultaneously sell the repurchased Shares to Softcat for cancellation. Softcat will announce any market repurchase of Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. 

Any purchases of Shares in relation to this announcement will be carried out on the London Stock Exchange in accordance with certain pre-set parameters outlined in the agreement with J.P. Morgan. These arrangements are in accordance with (and subject to the limits prescribed by) the Group's general authority to repurchase Shares granted by its shareholders at the annual general meeting ('AGM') held on 15 December 2025; Chapter 9 of the Financial Conduct Authority's UK Listing Rules; and applicable regulations, including those provisions of the Market Abuse Regulation (EU) No. 596/2014 (as incorporated into domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into domestic law by the European Union (Withdrawal) Act 2018).

The maximum number of Shares which may currently be purchased or committed to be purchased by Softcat under the Programme is 19,994,626, which is the maximum number pursuant to the relevant authorities granted by shareholders at Softcat's latest AGM.

 

For further information, please contact:

 

 

 

Softcat plc:

+44 (0)1628 403 403

Graham Charlton, Chief Executive Officer

Katy Mecklenburgh, Chief Financial Officer

Michael Watts, Head of Investor Relations

FTI Consulting LLP:

+44 (0)20 3727 1000

Ed Bridges

Matt Dixon

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLTLRIDIIR
Date   Source Headline
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results
9th Mar 20232:27 pmRNSDirector/PDMR Shareholding
1st Mar 202312:27 pmRNSTotal Voting Rights
8th Feb 20231:05 pmRNSDirector/PDMR Shareholding
1st Feb 202312:41 pmRNSTotal Voting Rights
17th Jan 20237:05 amRNSDirectorate Change
10th Jan 20232:23 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:34 amRNSTotal Voting Rights
3rd Jan 202311:31 amRNSDirector/PDMR Shareholding
22nd Dec 20223:00 pmRNSDirector/PDMR Shareholding
14th Dec 202210:12 amRNSResult of AGM
8th Dec 202212:29 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:57 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:54 pmRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSChief Financial Officer Appointment
1st Dec 202211:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.